In demyelinating diseases, such as multiple sclerosis, an upregulation of M
HC class I expression is thought to contribute to oligodendrocyte/myelin da
mage. In order to investigate potential physiological consequences of upreg
ulated MHC class I expression in oligodendrocytes, we generated transgenic
mice that overexpress H-2L(d) under the control of the proteolipid protein
(PLP) promoter (PLP-L-d mice). We focused our studies on the MHC class I mo
lecule H-2L(d), because of its unique intracellular transport characteristi
cs. In the CNS of PLP-L-d mice, H-2L(d) was expressed by oligodendrocytes.
Furthermore, H-2L(d) protein was transported to and expressed on the surfac
e of oligodendrocytes. Most importantly, this upregulation of MHC class I e
xpression in the CNS of PLP-L-d mice did not by itself result in a de- or d
ysmyelinating phenotype. These transgenic mice are likely to provide a uniq
ue and novel tool for the analysis of potential roles of MHC class I-mediat
ed mechanisms in demyelinating pathologies.